Format

Send to

Choose Destination
See comment in PubMed Commons below
Expert Rev Mol Diagn. 2004 Mar;4(2):157-67.

Signature of a silent killer: expression profiling in epithelial ovarian cancer.

Author information

1
Centre de recherche du Centre Hospitalier de l'Université de Montréal/Institut du cancer de Montréal, 1560, rue Sherbrooke est, Montréal, Quebec H2L 4M1, Canada. cecilelepage@yahoo.ca

Abstract

With the sequencing of the human genome and the simultaneous development of high-throughput strategies, cancer biologists have entered an exciting new area for gene expression analysis, with the ability to glimpse higher order patterns of genetic and epigenetic alterations in complex diseases. Ovarian cancer biologists are rising to the challenge of applying these new technologies to this silent killer, with the eventual goal of improving the quality of life and long-term survival of patients. This review provides a summary of the disease, a description of available technologies and their application to the ovarian cancer problem, as well as a discussion on the challenges and opportunities related to DNA microarray expression profiling-based research, including downstream clinical applications.

PMID:
14995903
DOI:
10.1586/14737159.4.2.157
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Taylor & Francis
    Loading ...
    Support Center